http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110684102-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e265350dab6194609cc7bf8a4aa38cfe |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba71a373ad5dc236a578d278973e7693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b98285eed65c6c31236cf82bcf24a40b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a393440f0a6ede38c04280ac496092e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d35c2ff901a492d9a9c6b957e030c735 |
| publicationDate | 2020-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110684102-A |
| titleOfInvention | A kind of SFTSV detection kit |
| abstract | The invention relates to a SFTSV detection kit, comprising a detection antibody, a solid substrate and a coated antibody coated on the solid substrate. The detection antibody and the coated antibody both include three complementarity determining regions CDR1-3, and the CDR1 sequence is Or include one of the sequences shown in SEQ ID NO:1-74, the CDR2 sequence is or include one of the sequences shown in SEQ ID NO:75-151, and the CDR3 sequence is or include one of the sequences shown in SEQ ID NO:152-232 . The invention conducts nanobody drug development and diagnostic kit development for SFTS with high lethality but lacks effective vaccines and specific antiviral drugs, screened nanobody VHH that specifically binds to GN, identified its CDR sequence, and constructed a human The synthesized antibody SNB provides potential new nanobody drugs for the clinical treatment of SFTS, and provides corresponding detection kits for the diagnosis of SFTS. |
| priorityDate | 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 586.